Does vitamin C deficiency increase lifestyle-associated vascular disease progression evidence based on experimental and clinical studies

Antioxidants and Redox Signaling

Volumn 19, Issue 17, 2013, Pages 2084-2104

  Tveden Nyborg, Pernille ^a   Lykkesfeldt, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ATORVASTATIN; BETA CAROTENE; BIOPTERIN; DEHYDROASCORBIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE TRANSPORTER 4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TETRAHYDROBIOPTERIN;

ADIPOCYTE; ASCORBIC ACID DEFICIENCY; ATHEROSCLEROSIS; BIOAVAILABILITY; BLOOD VESSEL FUNCTION; BLOOD VESSEL WALL; CALORIC INTAKE; CARDIOVASCULAR RISK; CELL ENERGY; CEREBROVASCULAR ACCIDENT; COLLAGEN SYNTHESIS; DEMETHYLATION; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; DISEASE COURSE; DYSLIPIDEMIA; ELECTRON; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENERGY METABOLISM; GLUCOSE TOLERANCE; HIGH RISK PATIENT; HUMAN; HYDROXYLATION; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRON ABSORPTION; LIFESTYLE; LIPID METABOLISM; LIPID PEROXIDATION; LIPID STORAGE; METABOLIC SYNDROME X; NITROSYLATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PASSIVE SMOKING; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SCURVY; SMOKING; SMOKING CESSATION; SMOKING HABIT; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; VASODILATATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HUMANS; LIFE STYLE; OBESITY; OXIDATION-REDUCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING;

EID: 84880765050     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5382     Document Type: Review

References (207)

1. Nutrition Canada Interpretive Standards. In: National Survey. Ottawa: Information Canada, 1973.
2. Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids: a report of the Panel on Dietary Antioxidants and Related Compounds, Subcommitties on Upper reference Levels of Nutrients and of the Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, food and Nutrition Board, Institue of Medicine, National Academy of Sciences. Washington, DC: National Academy Press, 2000.
3. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 23-33, 2002.
4. Aasheim ET, Hofso D, Hjelmesaeth J, Birkeland KI, and Bohmer T. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 87: 362-369, 2008.
5. Abdel-Wahab YHA, O'Harte FPM, Mooney MH, Barnett CR, and Flatt PR. Vitamin C supplementation decreases insulin glycation and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice. Metabolism 51: 514-517, 2002.
6. Agarwal M, Mehta PK, Dwyer JH, Dwyer KM, Shircore AM, Nordstrom CK, Sun P, Paul-Labrador M, Yang Y, and Merz CN. Differing relations to early atherosclerosis between vitamin C from supplements vs. food in the Los Angeles atherosclerosis study: a prospective cohort study. Open Cardiovasc Med J 6: 113-121, 2012.
7. Aguirre R and May JM. Inflammation in the vascular bed: importance of vitamin C. Pharmacol Ther 119: 96-103, 2008.
8. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, Sukhova GK, and Libby P. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97: 2433-2444, 1998.
9. Ames BN, McCann JC, Stampfer MJ, and Willett WC. Evidence-based decision making on micronutrients and chronic disease: long-term randomized controlled trials are not enough. Am J Clin Nutr 86: 522-523, 2007.
10. Andrikopoulos S. Obesity and type 2 diabetes: slow down! - Can metabolic deceleration protect the islet beta cell from excess nutrient-induced damage Mol Cell Endocrinol 316: 140-146, 2010.
11. Aycicek A, Erel O, and Kocyigit A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 47: 635-639, 2005.
12. Babaev VR, Whitesell RR, Li L, Linton MF, Fazio S, and May JM. Selective macrophage ascorbate deficiency suppresses early atherosclerosis. Free Radic Biol Med 50: 27-36, 2011.
13. Basili S, Tanzilli G, Mangieri E, Raparelli V, Di SS, Pignatelli P, and Violi F. Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers. JACC Cardiovasc Interv 3: 221-229, 2010.
14. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, and Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56: 952-964, 2012.
15. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, and Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132: 112-117, 2000.
16. Bendall JK, Alp NJ, Warrick N, Cai S, Adlam D, Rockett K, Yokoyama M, Kawashima S, and Channon KM. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res 97: 864-871, 2005.
17. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297: 842-857, 2007.
18. Block G. Ascorbic acid, blood pressure, and the American diet. Ann N Y Acad Sci 959: 180-187, 2002.
19. Block G, Jensen CD, Morrow JD, Holland N, Norkus EP, Milne GL, Hudes M, Dalvi TB, Crawford PB, Fung EB, Schumacher L, and Harmatz P. The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 45: 377-384, 2008.
20. Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, and Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 37: 261-267, 2001.
21. Block G, Mangels AR, Patterson BH, Levander OA, Norkus EP, and Taylor PR. Body weight and prior depletion affect plasma ascorbate levels attained on identical vitamin C intake: a controlled-diet study. J Am Coll Nutr 18: 628-637, 1999.
22. Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M, Vieth R, Weaver CM, and Zeisel SH. Evidence-based criteria in the nutritional context. Nutr Rev 68: 478-484, 2010.
23. Bohm F, Settergren M, and Pernow J. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo. Atherosclerosis 190: 408-415, 2007.
24. Boque N, Campion J, Milagro FI, Moreno-Aliaga MJ, and Martinez JA. Some cyclin-dependent kinase inhibitorsrelated genes are regulated by vitamin C in a model of diet-induced obesity. Biol Pharm Bull 32: 1462-1468, 2009.
25. Bowie AG and O'Neill LA. Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogenactivated protein kinase. J Immunol 165: 7180-7188, 2000.
26. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 300: 535-543, 1993.
27. Buettner GR and Schafer FQ. Ascorbate as an antioxidant. In: Vitamin C: It's Functions and Biochemistry in Animals and Plants, edited by Asard H, May JM and Smirnoff N. Oxford: BIOS Scientific, 2004.
28. Cahill LE and El-Sohemy A. Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency. Am J Clin Nutr 92: 1494-1500, 2010.
29. Campion J, Milagro FI, Fernandez D, and Martinez JA. Vitamin C supplementation influences body fat mass and steroidogenesis-related genes when fed a high-fat diet. Int J Vitam Nutr Res 78: 87-95, 2008.
30. Cangemi R, Angelico F, Loffredo L, Del BM, Pignatelli P, Martini A, and Violi F. Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radic Biol Med 43: 853-859, 2007.
31. Canoy D, Wareham N, Welch A, Bingham S, Luben R, Day N, and Khaw KT. Plasma ascorbic acid concentrations and fat distribution in 19068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study. Am J Clin Nutr 82: 1203-1209, 2005.
32. Carcamo JM, Pedraza A, Borquez-Ojeda O, and Golde DW. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry 41: 12995-13002, 2002.
33. Carr A and Frei B. Does vitamin C act as a pro-oxidant under physiological conditions FASEB J 13: 1007-1024, 1999.
34. Carr AC and Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 69: 1086-1107, 1999.
35. Chen K, Suh J, Carr AC, Morrow JD, Zeind J, and Frei B. Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload. Am J Physiol Endocrinol Metab 279: E1406-E1412, 2000.
36. Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, and Levine M. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A 104: 8749-8754, 2007.
37. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, and Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A 105: 11105-11109, 2008.
38. Choi JW, Pai SH, Kim SK, Ito M, Park CS, and Cha YN. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem 47: 1106-1109, 2001.
39. Choi JY, Jang EH, Park CS, and Kang JH. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Free Radic Biol Med 38: 806-816, 2005.
40. Codoner-Franch P, Valls-Belles V, Arilla-Codoner A, and Alonso-Iglesias E. Oxidant mechanisms in childhood obesity: the link between inflammation and oxidative stress. Transl Res 158: 369-384, 2011.
41. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, Pastorino AM, Lo C, V, and Sawamura T. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 276: 13750-13755, 2001.
42. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, and Manson JE. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 167: 1610-1618, 2007.
43. Crabtree MJ, Tatham AL, Al-Wakeel Y, Warrick N, Hale AB, Cai S, Channon KM, and Alp NJ. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J Biol Chem 284: 1136-1144, 2009.
44. Czernichow S, Vergnaud AC, Galan P, Arnaud J, Favier A, Faure H, Huxley R, Hercberg S, and Ahluwalia N. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr 90: 329-335, 2009.
45. D'uscio LV, Milstien S, Richardson D, Smith L, and Katusic ZS. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 92: 88-95, 2003.
46. da Silva VRG, Moreira EAM, Wilhelm D, de Miranda JX, Beninca JP, Vigil SVG, Moratelli AMB, Garlet TR, Meirelles MSD, Vannucchi H, and Frode TS. Proinflammatory and oxidative stress markers in patients submitted to Rouxen-Y gastric bypass after 1 year of follow-up. Eur J Clin Nutr 66: 891-899, 2012.
47. Das A, Dey N, Ghosh A, Das S, Chattopadhyay DJ, and Chatterjee IB. Molecular and cellular mechanisms of cigarette smoke-induced myocardial injury: prevention by vitamin C. PLoS One 7: e44151, 2012.
48. de Luca C and Olefsky JM. Inflammation and insulin resistance. FEBS Lett 582: 97-105, 2008.
49. de Sousa MG, Yugar-Toledo JC, Rubira M, Ferreira-Melo SE, Plentz R, Barbieri D, Consolim-Colombo F, Irigoyen MC, and Moreno H, Jr. Ascorbic acid improves impaired venous and arterial endothelium-dependent dilation in smokers. Acta Pharmacol Sin 26: 447-452, 2005.
50. Despres JP and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444: 881-887, 2006.
51. Dietrich M, Block G, Norkus EP, Hudes M, Traber MG, Cross CE, and Packer L. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr 77: 160-166, 2003.
52. Drake VJ and Frei B. Vitamin C in human disease prevention. In: Vitamins in the Prevention of Human Diseases, edited by Hermann W and Obeid R. Berlin: Walter de Gruyter, 2011, pp. 347-362.
53. Dror DK and Allen LH. Interventions with vitamins B6, B12 and C in pregnancy. Paediatr Perinat Epidemiol 26 Suppl 1: 55-74, 2012.
54. Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G, and Zweier JL. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci U S A 104: 15081-15086, 2007.
55. Dunbar A, Gotsis W, and Frishman W. Second-hand tobacco smoke and cardiovascular disease risk: an epidemiological review. Cardiol Rev 21: 94-100, 2012.
56. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to vitamin C and protection of DNA, proteins and lipids from oxidative damage (ID 129, 138, 143, 148), antioxidant function of lutein (ID 146), maintenance of vision (ID 141, 142), collagen formation (ID 130, 131, 136, 137, 149), function of the nervous system (ID 133), function of the immune system (ID 134), function of the immune system during and after extreme physical exercise (ID 144), non-haem iron absorption (ID 132, 147), energy-yielding metabolism (ID 135), and relief in case of irritation in the upper respiratory tract (ID 1714, 1715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J 7: 1226, 2009.
57. Ekuni D, Tomofuji T, Sanbe T, Irie K, Azuma T, Maruyama T, Tamaki N, Murakami J, Kokeguchi S, and Yamamoto T. Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress. Arch Oral Biol 54: 495-502, 2009.
58. Ellis GR, Anderson RA, Lang D, Blackman DJ, Morris RH, Morris-Thurgood J, McDowell IF, Jackson SK, Lewis MJ, and Frenneaux MP. Neutrophil superoxide anion - generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short-and long-term vitamin C therapy. J Am Coll Cardiol 36: 1474-1482, 2000.
59. Erbs S, Gielen S, Linke A, Mobius-Winkler S, Adams V, Baither Y, Schuler G, and Hambrecht R. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J 146: 280-285, 2003.
60. Erwin PA, Lin AJ, Golan DE, and Michel T. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 280: 19888-19894, 2005.
61. Flegal KM, Carroll MD, Ogden CL, and Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303: 235-241, 2010.
62. Fletcher AE, Breeze E, and Shetty PS. Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Am J Clin Nutr 78: 999-1010, 2003.
63. Fontana L, McNeill KL, Ritter JM, and Chowienczyk PJ. Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings. Br J Pharmacol 126: 730-734, 1999.
64. Ford ES, Giles WH, and Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287: 356-359, 2002.
65. Ford ES, Mokdad AH, Giles WH, and Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52: 2346-2352, 2003.
66. Forstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5: 338-349, 2008.
67. Forstermann U and Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol 164: 213-223, 2011.
68. Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, and Guerci AD. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol 106: 71-77, 2011.
69. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 54: 1113S-1118S, 1991.
70. Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 222: 196-204, 1999.
71. Frei B, Birlouez-Aragon I, and Lykkesfeldt J. Authors' perspective: what is the optimum intake of vitamin C in humans Crit Rev Food Sci Nutr 52: 815-829, 2012.
72. Friedman JM and Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
73. Frikke-Schmidt H and Lykkesfeldt J. Role of marginal vitamin C deficiency in atherogenesis: in vivo models and clinical studies. Basic Clin Pharmacol Toxicol 104: 419-433, 2009.
74. Frikke-Schmidt H and Lykkesfeldt J. Keeping the intracellular vitamin C at a physiologically relevant level in endothelial cell culture. Anal Biochem 397: 135-137, 2010.
75. Frikke-Schmidt H, Roursgaard M, Lykkesfeldt J, Loft S, Nojgaard JK, and Moller P. Effect of vitamin C and iron chelation on diesel exhaust particle and carbon black induced oxidative damage and cell adhesion molecule expression in human endothelial cells. Toxicol Lett 203: 181-189, 2011.
76. Frikke-Schmidt H, Tveden-Nyborg P, Birck MM, and Lykkesfeldt J. High dietary fat and cholesterol exacerbates chronic vitamin C deficiency in guinea pigs. Br J Nutr 105: 54-61, 2011.
77. Frikke-Schmidt H, Tveden-Nyborg P, and Lykkesfeldt J. Vitamin C in human nutrition. In: Vitamins in the Prevention of Human Diseases, edited by Hermann W and Obeid R. Berlin: Walter de Gruyter, 2011, pp. 323-347.
78. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761, 2004.
79. Gale CR, Ashurst HE, Powers HJ, and Martyn CN. Antioxidant vitamin status and carotid atherosclerosis in the elderly. Am J Clin Nutr 74: 402-408, 2001.
80. Gale CR, Martyn CN, Winter PD, and Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 310: 1563-1566, 1995.
81. Garcia OP, Ronquillo D, Caamano MD, Camacho M, Long KZ, and Rosado JL. Zinc, vitamin A, and vitamin C status are associated with leptin concentrations and obesity in Mexican women: results from a cross-sectional study. Nutr Metab 9: 59, 2012.
82. Garcia-Diaz D, Campion J, Milagro FI, and Martinez JA. Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem 305: 87-94, 2007.
83. Garcia-Diaz DF, Campion J, Milagro FI, Boque N, Moreno-Aliaga MJ, and Martinez JA. Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes. J Mol Endocrinol 45: 33-43, 2010.
84. Garcia-Diaz DF, Campion J, Quintero P, Milagro FI, Moreno-Aliaga MJ, and Martinez JA. Vitamin C modulates the interaction between adipocytes and macrophages. Mol Nutr Food Res 55: S257-S263, 2011.
85. Garcia-Saura MF, Saijo F, Bryan NS, Bauer S, Rodriguez J, and Feelisch M. Nitroso-redox status and vascular function in marginal and severe ascorbate deficiency. Antioxid Redox Signal 17: 937-950, 2012.
86. Grimble RF. The true cost of in-patient obesity: impact of obesity on inflammatory stress and morbidity. P Nutr Soc 69: 511-517, 2010.
87. Haidara MA, Khloussy H, Ammar H, and Aal Kassem LA. Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes. Med Sci Monit 10: BR41-BR46, 2004.
88. Hampl JS, Taylor CA, and Johnston CS. Vitamin C deficiency and depletion in the United States: The Third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health 94: 870-875, 2004.
89. Harding AH, Wareham NJ, Bingham SA, Khaw K, Luben R, Welch A, and Forouhi NG. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer - Norfolk prospective study. Arch Intern Med 168: 1493-1499, 2008.
90. Hayashi T, Juliet PA, Matsui-Hirai H, Miyazaki A, Fukatsu A, Funami J, Iguchi A, and Ignarro LJ. l-Citrulline and l-arginine supplementation retards the progression of highcholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci U S A 102: 13681-13686, 2005.
91. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T, and Munzel T. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 86: E36-E41, 2000.
92. Heitzer T, Just H, and Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94: 6-9, 1996.
93. Heitzer T, Schlinzig T, Krohn K, Meinertz T, and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673-2678, 2001.
94. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, and Werner ER. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276: 40-47, 2001.
95. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, and Briancon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164: 2335-2342, 2004.
96. Hewitson KS, McNeill LA, Elkins JM, and Schofield CJ. The role of iron and 2-oxoglutarate oxygenases in signalling. Biochem Soc Trans 31: 510-515, 2003.
97. Highdon J. Vitamin C. In: An Evidence-Based Approach to Vitamins and Minerals: Health benefits and Intake Recommendations. New York: Thieme, 2003, pp. 65-72.
98. Hirai N, Kawano H, Hirashima O, Motoyama T, Moriyama Y, Sakamoto T, Kugiyama K, Ogawa H, Nakao K, and Yasue H. Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C. Am J Physiol Heart Circ Physiol 279: H1172-H1178, 2000.
99. Horska A, Mislanova C, Bonassi S, Ceppi M, Volkovova K, and Dusinska M. Vitamin C levels in blood are influenced by polymorphisms in glutathione S-transferases. Eur J Nutr 50: 437-446, 2011.
100. Huang A, Vita JA, Venema RC, and Keaney JF, Jr. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275: 17399-17406, 2000.
101. Ignarro LJ, Napoli C, and Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90: 21-28, 2002.
102. Ivanov VO, Ivanova SV, and Niedzwiecki A. Ascorbate affects proliferation of guinea-pig vascular smooth muscle cells by direct and extracellular matrix-mediated effects. J Mol Cell Cardiol 29: 3293-3303, 1997.
103. Jackson TS, Xu A, Vita JA, and Keaney JF, Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83: 916-922, 1998.
104. Jacob RA. Assessment of human vitamin C status. J Nutr 120 Suppl 11: 1480-1485, 1990.
105. Johnston CS, Beezhold BL, Mostow B, and Swan PD. Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults. J Nutr 137: 1757-1762, 2007.
106. Johnston CS, Corte C, and Swan PD. Marginal vitamin C status is associated with reduced fat oxidation during submaximal exercise in young adults. Nutr Metab 3: 35, 2006.
107. Juraschek SP, Guallar E, Appel LJ, and Miller ER, III. Effects of vitamin C supplementation on blood pressure: a metaanalysis of randomized controlled trials. Am J Clin Nutr 95: 1079-1088, 2012.
108. Kakoki M, Hirata Y, Hayakawa H, Suzuki E, Nagata D, Tojo A, Nishimatsu H, Nakanishi N, Hattori Y, Kikuchi K, Nagano T, and Omata M. Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J Am Soc Nephrol 11: 301-309, 2000.
109. Kallner AB, Hartmann D, and Hornig DH. On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr 34: 1347-1355, 1981.
110. Kataja-Tuomola MK, Kontto JP, Mannisto S, Albanes D, and Virtamo J. Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur J Clin Nutr 65: 590-597, 2011.
111. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role Am J Physiol Heart Circ Physiol 281: H981-H986, 2001.
112. Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL, Rifai N, Selwyn AP, Creager MA, and Ganz P. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol 43: 629-634, 2004.
113. Kritchevsky SB, Shimakawa T, Tell GS, Dennis B, Carpenter M, Eckfeldt JH, Peacher-Ryan H, and Heiss G. Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 92: 2142-2150, 1995.
114. Kubota Y, Moriyama Y, Yamagishi K, Tanigawa T, Noda H, Yokota K, Harada M, Inagawa M, Oshima M, Sato S, and Iso H. Serum vitamin C concentration and hs-CRP level in middle-aged Japanese men and women. Atherosclerosis 208: 496-500, 2010.
115. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, and Huang PL. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104: 448-454, 2001.
116. Kuzkaya N, Weissmann N, Harrison DG, and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: 22546-22554, 2003.
117. Ladurner A, Schmitt CA, Schachner D, Atanasov AG, Werner ER, Dirsch VM, and Heiss EH. Ascorbate stimulates endothelial nitric oxide synthase enzyme activity by rapid modulation of its phosphorylation status. Free Radic Biol Med 52: 2082-2090, 2012.
118. Lagowska-Lenard M, Stelmasiak Z, and Bartosik-Psujek H. Influence of vitamin C on markers of oxidative stress in the earliest period of ischemic stroke. Pharmacol Rep 62: 751-756, 2010.
119. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
120. Langlois M, Duprez D, Delanghe J, De BM, and Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 103: 1863-1868, 2001.
121. Lehr HA, Frei B, and Arfors KE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A 91: 7688-7692, 1994.
122. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Jr., and Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93: 1107-1113, 1996.
123. Libby P. Changing concepts of atherogenesis. J Intern Med 247: 349-358, 2000.
124. Libby P and Aikawa M. Vitamin C, collagen, and cracks in the plaque. Circulation 105: 1396-1398, 2002.
125. Lin S, Thomas TC, Storlien LH, and Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57BI/6J mice. Int J Obesity 24: 639-646, 2000.
126. Lykkesfeldt J. Increased oxidative damage in vitamin C deficiency is accompanied by induction of ascorbic acid recycling capacity in young but not mature guinea pigs. Free Radic Res 36: 567-574, 2002.
127. Lykkesfeldt J. Smoking depletes vitamin C: Should smokers be recommended to take supplements In: Cigarette Smoke 6 Oxidative Stress, edited by Halliwell B and Poulsen HE. Springer Verlag, 2006, pp. 237-260.
128. Lykkesfeldt J, Bolbjerg ML, and Poulsen HE. Effect of smoking on erythorbic acid pharmacokinetics. Br J Nutr 89: 667-671, 2003.
129. Lykkesfeldt J, Christen S, Wallock LM, Chang HH, Jacob RA, and Ames BN. Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am J Clin Nutr 71: 530-536, 2000.
130. Lykkesfeldt J, Loft S, Nielsen JB, and Poulsen HE. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 65: 959-963, 1997.
131. Lykkesfeldt J and Poulsen HE. Is vitamin C supplementation beneficial Lessons learned from randomised controlled trials. Br J Nutr 103: 1251-1259, 2010.
132. Lykkesfeldt J, Prieme H, Loft S, and Poulsen HE. Effect of smoking cessation on plasma ascorbic acid concentration. BMJ 313: 91, 1996.
133. Lykkesfeldt J, Viscovich M, and Poulsen HE. Ascorbic acid recycling in human erythrocytes is induced by smoking in vivo. Free Radic Biol Med 35: 1439-1447, 2003.
134. Macias RI, Hierro C, de Juan SC, Jimenez F, Gonzalez-San MF, and Marin JJ. Hepatic expression of sodium-dependent vitamin C transporters: ontogeny, subtissular distribution and effect of chronic liver diseases. Br J Nutr 106: 1814-1825, 2011.
135. Maeda N, Hagihara H, Nakata Y, Hiller S, Wilder J, and Reddick R. Aortic wall damage in mice unable to synthesize ascorbic acid. Proc Natl Acad Sci U S A 97: 841-846, 2000.
136. Mah E, Matos MD, Kawiecki D, Ballard K, Guo Y, Volek JS, and Bruno RS. Vitamin C status is related to proinflammatory responses and impaired vascular endothelial function in healthy, college-aged lean and obese men. J Am Diet Assoc 111: 737-743, 2011.
137. Mark SD, Wang W, Fraumeni JF, Jr., Li JY, Taylor PR, Wang GQ, Dawsey SM, Li B, and Blot WJ. Do nutritional supplements lower the risk of stroke or hypertension Epidemiology 9: 9-15, 1998.
138. Mark SD, Wang W, Fraumeni JF, Jr., Li JY, Taylor PR, Wang GQ, Guo W, Dawsey SM, Li B, and Blot WJ. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial. Am J Epidemiol 143: 658-664, 1996.
139. Martin A and Frei B. Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vasc Biol 17: 1583-1590, 1997.
140. Massip L, Garand C, Paquet ER, Cogger VC, O'Reilly JN, Tworek L, Hatherell A, Taylor CG, Thorin E, Zahradka P, Le Couteur DG, and Lebel M. Vitamin C restores healthy aging in a mouse model for Werner syndrome. FASEB J 24: 158-172, 2010.
141. Mathieu P, Lemieux I, and Despres JP. Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 87: 407-416, 2010.
142. Matsumoto T, D'uscio LV, Eguchi D, Akiyama M, Smith LA, and Katusic ZS. Protective effect of chronic vitamin C treatment on endothelial function of apolipoprotein E-deficient mouse carotid artery. J Pharmacol Exp Ther 306: 103-108, 2003.
143. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 580: 2917-2921, 2006.
144. May JM. How does ascorbic acid prevent endothelial dysfunction Free Radic Biol Med 28: 1421-1429, 2000.
145. May JM, Li LY, and Qu ZC. Oxidized LDL up-regulates the ascorbic acid transporter SVCT2 in endothelial cells. Mol Cell Biochem 343: 217-222, 2010.
146. McNeill E and Channon K. The role of tetrahydrobiopterin in inflammation and cardiovascular disease. Thromb Haemost 108: 832-839, 2012.
147. Michels A and Frei B. Vitamin C. In: Biochemical, Physiological, and Molecular Aspects of Human Nutrition, edited by Stipanuk MH and Caudill MA. Saunders Elsevier, 2012, pp. 626-654.
148. Mitra S, Deshmukh A, Sachdeva R, Lu J, and Mehta JL. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci 342: 135-142, 2011.
149. Mortensen A and Lykkesfeldt J. Kinetics of acid-induced degradation of tetra-and dihydrobiopterin in relation to their relevance as biomarkers of endothelial function. Biomarkers 18: 55-62, 2012.
150. Mosdol A, Erens B, and Brunner EJ. Estimated prevalence and predictors of vitamin C deficiency within UK's lowincome population. J Public Health 30: 456-460, 2008.
151. Murad S, Sivarajah A, and Pinnell SR. Regulation of prolyl and lysyl hydroxylase activities in cultured human skin fibroblasts by ascorbic acid. Biochem Biophys Res Commun 101: 868-875, 1981.
152. Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, and Khaw KT. Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study. Am J Clin Nutr 87: 64-69, 2008.
153. Nakata Y and Maeda N. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. Circulation 105: 1485-1490, 2002.
154. Nishikawa Y, Tatsumi K, Matsuura T, Yamamoto A, Nadamoto T, and Urabe K. Effects of vitamin C on high blood pressure induced by salt in spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 49: 301-309, 2003.
155. Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, and Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 24: 1553-1561, 2006.
156. Nobili V, Manco M, Devito R, Di C, V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, and Angulo P. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 48: 119-128, 2008.
157. Nozaki M, Fukuhara A, Segawa K, Okuno Y, Abe M, Hosogai N, Matsuda M, Komuro R, and Shimomura I. Nitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 364: 33-39, 2007.
158. Odermarsky M, Lykkesfeldt J, and Liuba P. Poor vitamin C status is associated with increased carotid intima-media thickness, decreased microvascular function, and delayed myocardial repolarization in young patients with type 1 diabetes. Am J Clin Nutr 90: 447-452, 2009.
159. Orbe J, Rodriguez JA, Arias R, Belzunce M, Nespereira B, Perez-Ilzarbe M, Roncal C, and Paramo JA. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 167: 45-53, 2003.
160. Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, Hardies J, and Cusi K. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 35: 873-878, 2012.
161. Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15: 1911-1926, 2011.
162. Papparella I, Ceolotto G, Berto L, Cavalli M, Bova S, Cargnelli G, Ruga E, Milanesi O, Franco L, Mazzoni M, Petrelli L, Nussdorfer GG, and Semplicini A. Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res 73: 432-438, 2007.
163. Pellegrini MP, Newby DE, Johnston NR, Maxwell S, and Webb DJ. Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers. J Cardiovasc Pharmacol 44: 117-124, 2004.
164. Ponnuswamy P, Schrottle A, Ostermeier E, Gruner S, Huang PL, Ertl G, Hoffmann U, Nieswandt B, and Kuhlencordt PJ. eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PLoS One 7: e30193, 2012.
165. Preston AM, Rodriguez C, and Rivera CE. Plasma ascorbate in a population of children: influence of age, gender, vitamin C intake, BMI and smoke exposure. P R Health Sci J 25: 137-142, 2006.
166. Preston AM, Rodriguez C, Rivera CE, and Sahai H. Influence of environmental tobacco smoke on vitamin C status in children. Am J Clin Nutr 77: 167-172, 2003.
167. Pryor WA and Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 686: 12-27, 1993.
168. Ramirez RJ, Hubel CA, Novak J, DiCianno JR, Kagan VE, and Gandley RE. Moderate ascorbate deficiency increases myogenic tone of arteries from pregnant but not virgin ascorbate-dependent rats. Hypertension 47: 454-460, 2006.
169. Ravindran RD, Vashist P, Gupta SK, Young IS, Maraini G, Camparini M, Jayanthi R, John N, Fitzpatrick KE, Chakravarthy U, Ravilla TD, and Fletcher AE. Prevalence and risk factors for vitamin C deficiency in North and South India: a two centre population based study in people aged 60 years and over. PLoS One 6: e28588, 2011.
170. Ray T, Maity PC, Banerjee S, Deb S, Dasgupta AK, Sarkar S, and Sil AK. Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model. J Atheroscler Thromb 17: 817-827, 2010.
171. Rayment SJ, Shaw J, Woollard KJ, Lunec J, and Griffiths HR. Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression. Biochem Biophys Res Commun 308: 339-345, 2003.
172. Rezazadeh A, Yazdanparast R, and Molaei M. Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress. J Biomed Sci 19: 26, 2012.
173. Roberts LJ, Traber MG, and Frei B. Vitamins E and C in the prevention of cardiovascular disease and cancer in men. Free Radic Biol Med 46: 1558, 2009.
174. Rodriguez JA, Grau A, Eguinoa E, Nespereira B, Perez-Ilzarbe M, Arias R, Belzunce MS, Paramo JA, and Martinez-Caro D. Dietary supplementation with vitamins C and E prevents downregulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro. Atherosclerosis 165: 33-40, 2002.
175. Rossi AC and Mullin PM. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis. Eur J Obstet Gynecol Reprod Biol 158: 9-16, 2011.
176. Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen TP, Valkonen VP, Ristonmaa U, Lakka HM, Vanharanta M, Salonen JT, and Poulsen HE. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107: 947-953, 2003.
177. Sanchez-Lugo L, Mayer-Davis EJ, Howard G, Selby JV, Ayad MF, Rewers M, and Haffner S. Insulin sensitivity and intake of vitamins E and C in African American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study (IRAS). Am J Clin Nutr 66: 1224-1231, 1997.
178. Schectman G. Estimating ascorbic acid requirements for cigarette smokers. Ann N Y Acad Sci 686: 335-345, 1993.
179. Schleicher RL, Carroll MD, Ford ES, and Lacher DA. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutr 90: 1252-1263, 2009.
180. Schofield CJ and Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354, 2004.
181. Schofield CJ and Zhang Z. Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr Opin Struct Biol 9: 722-731, 1999.
182. Schulz E, Anter E, and Keaney JF, Jr. Oxidative stress, antioxidants, and endothelial function. Curr Med Chem 11: 1093-1104, 2004.
183. Schulz E, Jansen T, Wenzel P, Daiber A, and Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10: 1115-1126, 2008.
184. Scorza G, Pietraforte D, and Minetti M. Role of ascorbate and protein thiols in the release of nitric oxide from S-nitrosoalbumin and S-nitroso-glutathione in human plasma. Free Radic Biol Med 22: 633-642, 1997.
185. Senmaru T, Yamazaki M, Okada H, Asano M, Fukui M, Nakamura N, Obayashi H, Kondo Y, Maruyama N, Ishigami A, and Hasegawa G. Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice. J Clin Biochem Nutr 50: 114-118, 2012.
186. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, and Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300: 2123-2133, 2008.
187. Shehzad A, Iqbal W, Shehzad O, and Lee YS. Adiponectin: regulation of its production and its role in human diseases. Horm Int J Endocrinol 11: 8-20, 2012.
188. Shinke T, Shite J, Takaoka H, Hata K, Inoue N, Yoshikawa R, Matsumoto H, Masai H, Watanabe S, Ozawa T, Otake H, Matsumoto D, Hirata K, and Yokoyama M. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction. Am Heart J 154: 645-648, 2007.
189. Simon JA, Hudes ES, and Browner WS. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults. Epidemiology 9: 316-321, 1998.
190. Simon JA, Murtaugh MA, Gross MD, Loria CM, Hulley SB, and Jacobs DR, Jr. Relation of ascorbic acid to coronary artery calcium: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 159: 581-588, 2004.
191. Smith JL and Hodges RE. Serum levels of vitamin C in relation to dietary and supplemental intake of vitamin C in smokers and nonsmokers. Ann N Y Acad Sci 498: 144-152, 1987.
192. Stepanova M and Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol 10: 646-650, 2012.
193. Suganami T and Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 88: 33-39, 2010.
194. Takase B, Etsuda H, Matsushima Y, Ayaori M, Kusano H, Hamabe A, Uehata A, Ohsuzu F, Ishihara M, and Kurita A. Effect of chronic oral supplementation with vitamins on the endothelial function in chronic smokers. Angiology 55: 653-660, 2004.
195. Timpson NJ, Forouhi NG, Brion MJ, Harbord RM, Cook DG, Johnson P, McConnachie A, Morris RW, Rodriguez S, Luan J, Ebrahim S, Padmanabhan S, Watt G, Bruckdorfer KR, Wareham NJ, Whincup PH, Chanock S, Sattar N, Lawlor DA, and Davey SG. Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with > 15,000 participants. Am J Clin Nutr 92: 375-382, 2010.
196. Trobs M, Renner T, Scherer G, Heller WD, Geiss HC, Wolfram G, Haas GM, and Schwandt P. Nutrition, antioxidants, and risk factor profile of nonsmokers, passive smokers and smokers of the Prevention Education Program (PEP) in Nuremberg, Germany. Prev Med 34: 600-607, 2002.
197. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, and Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439: 811-816, 2006.
198. Valdecantos MP, Perez-Matute P, Quintero P, and Martinez JA. Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different. Redox Report 15: 207-216, 2010.
199. Valkonen M and Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation 97: 2012-2016, 1998.
200. Vasquez-Vivar J, Whitsett J, Martasek P, Hogg N, and Kalyanaraman B. Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical. Free Radic Biol Med 31: 975-985, 2001.
201. Vincent HK, Bourguignon CM, Weltman AL, Vincent KR, Barrett E, Innes KE, and Taylor AG. Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults. Metabolism 58: 254-262, 2009.
202. Viscovich M, Lykkesfeldt J, and Poulsen HE. Vitamin C pharmacokinetics of plain and slow release formulations in smokers. Clin Nutr 23: 1043-1050, 2004.
203. Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, and Whincup PH. Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr 83: 567-574, 2006.
204. Wells WW, Dou CZ, Dybas LN, Jung CH, Kalbach HL, and Xu DP. Ascorbic acid is essential for the release of insulin from scorbutic guinea pig pancreatic islets. Proc Natl Acad Sci U S A 92: 11869-11873, 1995.
205. Willis GC. An experimental study of the intimal ground substance in atherosclerosis. Can Med Assoc J 69: 17-22, 1953.
206. Wu F, Wilson JX, and Tyml K. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integr Comp Physiol 285: R50-R56, 2003.
207. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, and Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362, 2005.